Oral efficacy of Δ(9)-tetrahydrocannabinol and cannabidiol in a mouse neuropathic pain model
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Oral efficacy of Δ(9)-tetrahydrocannabinol and cannabidiol in a mouse neuropathic pain model
Authors
Keywords
-
Journal
NEUROPHARMACOLOGY
Volume 189, Issue -, Pages 108529
Publisher
Elsevier BV
Online
2021-03-18
DOI
10.1016/j.neuropharm.2021.108529
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Evaluation of the preclinical analgesic efficacy of naturally derived, orally administered oil forms of Δ9-tetrahydrocannabinol (THC), cannabidiol (CBD), and their 1:1 combination
- (2020) Katja Linher-Melville et al. PLoS One
- Pharmacokinetics of oral and intravenous cannabidiol and its antidepressant-like effects in chronic mild stress mouse model
- (2019) Chen Xu et al. ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY
- Clinicians’ Guide to Cannabidiol and Hemp Oils
- (2019) Harrison J. VanDolah et al. MAYO CLINIC PROCEEDINGS
- Public health implications of legalising the production and sale of cannabis for medicinal and recreational use
- (2019) Wayne Hall et al. LANCET
- Different receptor mechanisms underlying phytocannabinoid‐ versus synthetic cannabinoid‐induced tetrad effects: Opposite roles of CB 1 /CB 2 versus GPR55 receptors
- (2019) Xiao‐Fei Wang et al. BRITISH JOURNAL OF PHARMACOLOGY
- Orally consumed cannabinoids provide long-lasting relief of allodynia in a mouse model of chronic neuropathic pain
- (2019) Antony D. Abraham et al. NEUROPSYCHOPHARMACOLOGY
- The Pharmacokinetics and the Pharmacodynamics of Cannabinoids
- (2018) C.J. Lucas et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Practical considerations in medical cannabis administration and dosing
- (2018) Caroline A. MacCallum et al. European Journal of Internal Medicine
- Cannabis and cannabinoids for the treatment of people with chronic non-cancer pain conditions
- (2018) Emily Stockings et al. PAIN
- Chronic Pain Treatment With Cannabidiol in Kidney Transplant Patients in Uruguay
- (2018) L. Cuñetti et al. TRANSPLANTATION PROCEEDINGS
- The effect of Pro NanoLipospheres (PNL) formulation containing natural absorption enhancers on the oral bioavailability of delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) in a rat model
- (2017) Irina Cherniakov et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Cannabis constituent synergy in a mouse neuropathic pain model
- (2017) Sherelle L. Casey et al. PAIN
- Effects of Delta-9-Tetrahydrocannabinol and Cannabidiol on Cisplatin-Induced Neuropathy in Mice
- (2016) Hannah Harris et al. PLANTA MEDICA
- Chronic Cannabinoid Receptor 2 Activation Reverses Paclitaxel Neuropathy Without Tolerance or Cannabinoid Receptor 1–Dependent Withdrawal
- (2015) Liting Deng et al. BIOLOGICAL PSYCHIATRY
- Cannabinoids for Medical Use
- (2015) Penny F. Whiting et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis
- (2015) Nanna B Finnerup et al. LANCET NEUROLOGY
- A Simplified Up-Down Method (SUDO) for Measuring Mechanical Nociception in Rodents Using von Frey Filaments
- (2014) Robert P Bonin et al. Molecular Pain
- Early phytocannabinoid chemistry to endocannabinoids and beyond
- (2014) Raphael Mechoulam et al. NATURE REVIEWS NEUROSCIENCE
- Cannabidiol inhibits paclitaxel-induced neuropathic pain through 5-HT1Areceptors without diminishing nervous system function or chemotherapy efficacy
- (2013) Sara Jane Ward et al. BRITISH JOURNAL OF PHARMACOLOGY
- A new definition of neuropathic pain
- (2011) Troels S. Jensen et al. PAIN
- Cannabidiol potentiates Δ9-tetrahydrocannabinol (THC) behavioural effects and alters THC pharmacokinetics during acute and chronic treatment in adolescent rats
- (2011) Charlotte Klein et al. PSYCHOPHARMACOLOGY
- Recommendations for the Pharmacological Management of Neuropathic Pain: An Overview and Literature Update
- (2010) Robert H. Dworkin et al. MAYO CLINIC PROCEEDINGS
- Cannabinoid-Mediated Modulation of Neuropathic Pain and Microglial Accumulation in a Model of Murine Type I Diabetic Peripheral Neuropathic Pain
- (2010) Cory C Toth et al. Molecular Pain
- Cannabinoids as pharmacotherapies for neuropathic pain: From the bench to the bedside
- (2009) Elizabeth J. Rahn et al. Neurotherapeutics
- Decreased basal endogenous opioid levels in diabetic rodents: Effects on morphine and delta-9-tetrahydrocannabinoid-induced antinociception
- (2008) Jovan Williams et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Cannabidiol potentiates pharmacological effects of Δ9-tetrahydrocannabinol via CB1 receptor-dependent mechanism
- (2007) Kazuhide Hayakawa et al. BRAIN RESEARCH
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started